![Jeffrey Friedman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeffrey Friedman
Director/Board Member at DTx Pharma, Inc.
Network origin in Jeffrey Friedman first degree
Entity | Entity type | Industry | |
---|---|---|---|
DTx Pharma, Inc.
![]() DTx Pharma, Inc. Pharmaceuticals: MajorHealth Technology DTx Pharma, Inc. engages in the provision of biotechnology solutions. It focuses on the utilization of fatty acids to enable the delivery of RNA therapeutics to tissues and organ systems beyond the liver. The company was founded by Arthur T. Suckow, John Grundy, and Adam Pavlicek in August 2017 and is headquartered in San Diego, CA.
9
| Subsidiary | Pharmaceuticals: Major | 9 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jeffrey Friedman via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ceregene, Inc.
![]() Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Tioga Pharmaceuticals, Inc.
![]() Tioga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tioga Pharmaceuticals, Inc. manufactures pharmaceutical products. It develops therapies for the treatment of pruritus. The company was founded by Stuart J. Collinson in 2005 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
RECEPTOS INC | Pharmaceuticals: Major | Director of Finance/CFO | |
PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
Access Industries LLC | Corporate Officer/Principal | ||
The Boston Consulting Group, Inc.
![]() The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
San Diego State University | College/University | Undergraduate Degree | |
University of Alberta | College/University | Doctorate Degree | |
University of British Columbia | College/University | Undergraduate Degree | |
Simon Fraser University | College/University | Undergraduate Degree | |
University of California San Diego | College/University | Undergraduate Degree | |
University of Michigan | College/University | Doctorate Degree | |
University of San Diego | College/University | Graduate Degree | |
BIOCOM
![]() BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Chairman | |
New Leaf Venture Partners LLC
![]() New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Investment Managers | Private Equity Investor | |
The State Bar of California
![]() The State Bar of California Miscellaneous Commercial ServicesCommercial Services The State Bar of California operates as an official attorney licensing agency. The non-profit company is based in San Francisco, CA. Elizabeth Rindskopf Parker has been the CEO of the company since 2015. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
MUSC Foundation for Research Development | Director/Board Member | ||
CONNECT
![]() CONNECT Miscellaneous Commercial ServicesCommercial Services CONNECT creates and scales companies in the technology and life sciences sectors. It creates an environment in which entrepreneurs and C-suite executives have access to the people, capital, and technology resources. The organization was founded in 1985 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Orphagen Pharmaceuticals
![]() Orphagen Pharmaceuticals Pharmaceuticals: MajorHealth Technology Orphagen Pharmaceuticals develops and manufactures drugs. The company was founded by Scott Thacher in 2001 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
La Jolla Playhouse, Inc.
![]() La Jolla Playhouse, Inc. Miscellaneous Commercial ServicesCommercial Services La Jolla Playhouse, Inc. provides educational opportunities for children, teens, and adults interested in theatre arts. The company was founded by Gregory Peck, Dorothy McGuire, and Mel Ferrer in 1947 and is headquartered in La Jolla, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Amplyx Pharmaceuticals, Inc.
![]() Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director of Finance/CFO | |
OTONOMY | Biotechnology | Chief Tech/Sci/R&D Officer | |
Avelas Biosciences, Inc.
![]() Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | Medical/Nursing Services | Director/Board Member | |
University of Michigan Medical School | College/University | Doctorate Degree | |
Codagenix, Inc.
![]() Codagenix, Inc. Medical/Nursing ServicesHealth Services Codagenix, Inc. provides platform technology to construct viral vaccines against multiple targets. It focuses on SAVE platform technology that utilizes computer-based rational design of viral genomes for the design and construction of vaccines for a range of medically important human diseases. The company was founded by J. Robert Coleman, Eckard Wimmer, Charlie Petty and Steffen Mueller in 2009 and is headquartered in Farmingdale, NY. | Medical/Nursing Services | Director/Board Member | |
Jnana Therapeutics, Inc.
![]() Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
University of Illinois At Urbana–Champaign | College/University | Undergraduate Degree | |
GOSSAMER BIO, INC. | Pharmaceuticals: Major | Treasurer | |
Indefinite Integral, Inc.
![]() Indefinite Integral, Inc. Financial ConglomeratesFinance Indefinite Integral, Inc. is a financial services company, which develops monetary contracts based on block chain. The company was founded by James Prestwich and is headquartered in San Francisco, CA. | Financial Conglomerates | Director of Finance/CFO | |
Cerebral Therapeutics, Inc.
![]() Cerebral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cerebral Therapeutics, Inc. develops neurological therapeutics for uncontrolled neurological diseases. It is a clinical-stage company dedicated to improving the lives of patients living with uncontrolled neurological diseases, with an initial focus on refractory epilepsy. The firm offers long-term implanted drug-device combination therapies that bypass the blood-brain barrier to deliver optimal doses of specially formulated neurological therapeutics directly into the target region of the brain. The company was founded by Daniel J. Abrams and James P. Kelleher and is headquartered in Aurora, CO. | Miscellaneous Commercial Services | Director/Board Member | |
Locanabio, Inc.
![]() Locanabio, Inc. Packaged SoftwareTechnology Services Locana, Inc. engages in the provision of ribonucleic acid targeting gene therapy. Its platform technology addresses a wide spectrum of human genetic diseases. It has advanced a powerful modular RNA targeting-effector approach to optimize and advance therapeutic candidates that is distinct from DNA-targeted approaches and nucleic acid-based RNA targeting. The company was founded by Gene Yeo and David Nelles in 2016 and is headquartered in San Diego, CA. | Packaged Software | Chief Tech/Sci/R&D Officer | |
Access Biotechnology (Venture Capital)
![]() Access Biotechnology (Venture Capital) Investment ManagersFinance Access Biotechnology (Access Biotechnology) is a venture capital subsidiary of Access Industries, Inc. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
PANDION THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
TEGA Therapeutics, Inc.
![]() TEGA Therapeutics, Inc. BiotechnologyHealth Technology TEGA Therapeutics, Inc. produces recombinant heparan sulfate and enzyme replacement therapies for lysosomal storage diseases. The company is based in San Diego, CA. Glass, Jeffrey D. Esko. TEGA Therapeutics was founded by Yitzhak Tor, Timothy Scott, Charles A. Timothy Scott has been the CEO since incorporation. | Biotechnology | Chief Executive Officer | |
DOT Therapeutics-2, Inc.
![]() DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
Emergence Therapeutics AG
![]() Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Forge Biologics, Inc.
![]() Forge Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Forge Biologics, Inc. operates as a gene therapy development engine, focused on enabling access to life changing gene therapies. The firm is a viral vector gene therapy manufacturing and development company with the dual platform of CDMO capabilities and the development of proprietary gene therapy products. The company was founded by Timothy J. Miller and Jaysson Eicholtz and is headquartered in Columbus, OH. | Miscellaneous Commercial Services | Director/Board Member | |
ACELYRIN, INC. | Pharmaceuticals: Major | Director/Board Member | |
Hemab ApS
![]() Hemab ApS BiotechnologyHealth Technology Hemab ApS develops antibodies for the treatment of rare bleeding disorders. The company is based in Copenhagen, Denmark. The Danish company was founded in 2019 by Johan Henrik Faber. Benny Sorensen has been the CEO of the company since 2020. | Biotechnology | Director/Board Member | |
Kira Pharmaceuticals (US) LLC
![]() Kira Pharmaceuticals (US) LLC Pharmaceuticals: MajorHealth Technology Part of Kira Pharmaceuticals (Suzhou) Co., Ltd., Kira Pharmaceuticals (US) LLC develops transformative therapies for people with complement-mediated diseases. The company is based in Cambridge, MA. The company was founded by Gonghua Pan, Wenru Song. Frederick C. Beddingfield has been the CEO of the company since 2020. | Pharmaceuticals: Major | Director/Board Member | |
DAY ONE BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
RESEARCH ALLIANCE CORP. II | Financial Conglomerates | Founder | |
Mariana Oncology, Inc.
![]() Mariana Oncology, Inc. BiotechnologyHealth Technology Mariana Oncology, Inc., also known as Curie Therapeutics, is a radiopharmaceuticals company that specializes in developing safe and effective targeted radiopharmaceuticals for cancer treatment. The company is based in Woburn, MA and was founded by Simon Read, who has been the CEO since incorporation. The company's radiopharmaceuticals are designed to deliver alpha and beta-emitting radionuclide payloads to carefully selected biological targets. | Biotechnology | Director/Board Member | |
Matchpoint Therapeutics, Inc.
![]() Matchpoint Therapeutics, Inc. BiotechnologyHealth Technology Matchpoint Therapeutics, Inc. is a biotechnology company based in Cambridge, MA. The company aims to discover and develop precision covalent medicines to transform the treatment of immune diseases and other serious illnesses. Matchpoint's proprietary Advanced Covalent Exploration (ACE) platform integrates advanced chemoproteomics, machine learning, and covalent chemistry library evolution. The company was founded by Jianwei Che, Edward Chouchani, Tinghu Zhang, Nathanael S. Gray, and the CEO is G. Andre Turenne. | Biotechnology | Director/Board Member | |
BIORA THERAPEUTICS, INC. | Medical/Nursing Services | Director/Board Member |
Statistics
International
United States | 45 |
Canada | 4 |
Germany | 2 |
Denmark | 2 |
Sectoral
Health Technology | 24 |
Consumer Services | 10 |
Commercial Services | 8 |
Finance | 5 |
Health Services | 4 |
Operational
Director/Board Member | 35 |
Founder | 8 |
Director of Finance/CFO | 8 |
Undergraduate Degree | 7 |
Chief Tech/Sci/R&D Officer | 6 |
Most connected contacts
Insiders | |
---|---|
Dan Becker | 16 |
Matthew Hammond | 13 |
Timothy Scott | 12 |
Katherine Bishop | 10 |
Jill Howe | 10 |
Denise Bevers | 8 |
John Grundy | 2 |
Arthur Suckow | 1 |
Alan Joelson | 1 |
- Stock Market
- Insiders
- Jeffrey Friedman
- Company connections